Better treatments for Parkinson’s disease depend on increasing our understanding of why Parkinson’s develops and how it progresses. The Parkinson’s Precision Medicine Initiative (PPMI) has spent fifteen years developing an unparalleled collection of data from thousands of volunteers all over the world and has delivered critical insight into the disease.
In this episode of The Michael J. Fox Foundation Parkinson’s Podcast, Maggie Kuhl, vice president of patient engagement at MJFF, reflects back with study leadership and a long-time participant on how the study began, how it has impacted Parkinson’s research over the last decade and a half and how the study is expanding to answer even more questions in the coming years. She leads a conversation about these efforts with:
Kenneth Marek, MD, co-founder of the Institute for Neurodegenerative Disorders and PPMI’s principal investigator
Sohini Chowdhury, MJFF’s chief program officer
Donna Rajkovic, who was diagnosed with Parkinson’s disease in 2012 and joined PPMI the same year
If you’d rather listen on the go, subscribe to the show on iTunes or wherever you get your podcasts. If you enjoyed what you heard, share it with a friend or leave a review. It helps listeners like you find and support our mission.
View a transcript of this podcast.
PPMI is recruiting volunteers. Join the study that’s changing everything.